Navigation Links
Essilor's First-Half 2008 Results
Date:8/27/2008


CHARENTON-LE-PONT, France, August 28 /PRNewswire-FirstCall/ --

- A Solid First-Half Performance

- Net Profit Up 16.8% at Constant Exchange Rates

- Essilor Launches a Share Buyback Program

The Board of Directors of Essilor International, the world leader in ophthalmic optics, has approved the financial statements for the six months ended June 30, 2008.

EUR millions First-half 2008 First-half 2007 % change % change

at constant

exchange

rates

Revenue 1,520.2 1,476.9 +2.9% +9.6%

Contribution margin 18.2% 18.1% - -

Profit attributable 198.3 181.9 +9.0% +16.8%

to equity holders of

Essilor International

Basic earnings per 0.96 0.88(1) +8.1% +15.8%

share (in EUR)

(1) Adjusted for the two-for-one stock split on July 16, 2007

The highlights of the first half were:

- Growth (excluding the currency effect) of 9.6%

- Sustained business growth in North America, Latin America,

the ASEAN countries, China and India.

- Successful new products, notably the sixth-generation of

Transitions(R) variable-tint lenses and Crizal Avance(TM)

anti-reflective lenses with Scotchgard(TM) Protector.

- High profitability, with a contribution margin of 18.2% that

was slightly higher than the figure reported for full-year 2007.

- A 9% increase in profit attributable to equity holders of

Essilor International, for a net margin of 13%.

- An ongoing external growth strategy, with the acquisition of

13 companies representing approximately EUR70 million in full-year

revenue. '/>"/>

SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Biopure Announces 2008 Third Quarter Financial Results
2. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
3. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
4. Arpida Reports Interim Results for Six Months to 30 June 2008
5. Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
6. Rosetta Genomics Reports Second Quarter 2008 Financial Results
7. VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
8. Arno Therapeutics Announces Second Quarter 2008 Financial Results
9. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
10. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
11. Yongye Biotechnology International Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... NY (PRWEB) January 15, 2014 The Microcompetition ... a major disease. One of these latent viruses is the ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory ... theory, a study found that RA patients have high concentrations ...
(Date:1/15/2014)... 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... a leading Russian pharmaceutical company, to develop and commercialize ... Federation , Turkey and ... a novel antibiotic for the treatment of bacterial infections ...
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up their ... of them wrote: "Take better care of my furry companion." Nowadays ... clothes and top-brand carrying cases to take the little canine or ... also feel compelled to buy some pricey toys at the pet ...
(Date:1/14/2014)... January 14, 2014 In recent years, ... and methods in product development and promotion has led ... This mistrust, fueled by concerns about the insidious impact ... reports of spectacular fines to the world’s biggest pharmas ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... /PRNewswire/ - Sirius Genomics, a developer of pharmacogenomic diagnostics, ... Directors at its recent Annual General Meeting. The six-member ... Dreismann, Mr. Jim Heppell, Mr. Amos Michelson, Dr. Bradley ... expertise in molecular diagnostics, commercialization and personalized medicine experience ...
... ... Industry Opportunities at Major Food Conference , ... Anaheim, Calif. (Vocus) June 7, 2009 -- The next generation ... provide nutritionally enhanced oil with the highest oleic content in soybeans under commercial development. ...
... Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company ... findings from the first of four Phase 3 trials of ... These data were presented in one oral and two ... Sessions in New Orleans, Louisiana. , , The ...
Cached Biology Technology:Sirius Genomics Announces 2009 Board of Directors 2Plenish™ High Oleic Soybean Oil Offers Trans Fat Solution with Superior Performance 2Plenish™ High Oleic Soybean Oil Offers Trans Fat Solution with Superior Performance 3Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions 2Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions 3Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions 4Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions 5
(Date:4/17/2014)... Orange, NJ. April 16, 2014. Kessler Foundation has ... $1.8 million from the Department of Defense Spinal ... is principal investigator for the randomized, double-blinded, controlled, ... improve bone and muscle strength after spinal cord ... Performance & Engineering Research at Kessler Foundation. Two ...
(Date:4/17/2014)... N.M. A credit-card-sized anthrax detection cartridge developed at ... business makes testing safer, easier, faster and cheaper. ... anthrax, is commonly found in soils all over the ... in both humans and animals. The bacteria can survive ... B. anthracis may occur through skin contact, ...
(Date:4/17/2014)... Kansas State University engineer has developed a patented ... improvised explosive devices. The same technique could help ... Steven M. and Kay L. Theede chair in ... engineering, and his research team have created a ... in car trunks. The distance detection method ...
Breaking Biology News(10 mins):Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3Patented research remotely detects nitrogen-rich explosives 2
... cancer-preventing potential of berries, red wine, and other foods are ... current issue of Chemical & Engineering News (C&EN), ACS, weekly ... substances in those foods and turn their potential into reality. ... have tried for years to develop drugs that reduce the ...
... team of scientists from the University of Nevada, Reno, ... has returned from a two-week expedition to Guatemala,s tropical ... solutions to the algae blooms that have assailed the ... The lake,s water is contaminated with watershed runoff ...
... Researchers in the University of Alabama at Birmingham (UAB) departments ... grant from the National Heart, Lung, and Blood Institute (NHLBI) ... to the potentially harmful changes in red blood cells that ... The UAB study will focus on the mechanisms by which ...
Cached Biology News:American team of scientists help protect Guatemala's Lake Atitlan 2American team of scientists help protect Guatemala's Lake Atitlan 3NHLBI grants $1.47 million to study red blood cell transfusion storage times and bioactivity 2
The filter 640DF35 for the Molecular Imager FX is a band pass filter for Texas Red dye....
... Situ Apoptosis Detection Kit detects apoptosis ... method, utilizing an anti-digoxigenin antibody with ... indirect immunofluorescence staining for 40 samples. ... microscopy or flow cytometry (requires a ...
... is a single-step staining method for labeling ... flow cytometry. The kit contains all the ... cells including: positive and negative control cells ... rinsing buffers for processing individual steps in ...
... The BioGenex VISION Sytem is a ... comes with proprietary digital imaging and ... digital image acquisition, analysis, archving/retrieval and ... comes with the industry's fastest scanning ...
Biology Products: